Clinical trial

Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip

NCT00451360 · Laboratoires NEGMA, Industry · Completed

Key facts

NCT number NCT00451360
Title Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip
Official title Evaluation of the CHOndromodulating Effect of DIAcerein in Osteoarthritis of the Hip. ECHODIAH.
Acronym ECHODIAH
Lead sponsor Laboratoires NEGMA, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hip Osteoarthritis
Intervention type Drug
Interventions diacerein
Enrollment 500
Start date Mar 1, 1993
Completion Apr 1, 1997
First posted Mar 23, 2007
Last update posted Jul 25, 2008
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies